Online citations, reference lists, and bibliographies.
← Back to Search

The Role Of Salicylic Acid In The Treatment Of Psoriasis

M. Lebwohl
Published 1999 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Psoriasis is a chronic, relapsing disorder in which the skin becomes scaly and inflamed; it affects 1–3% of the population of the U.S.A.1 In addition to classic plaque psoriasis, the condition can present in a variety of forms, including guttate, erythrodermic, inverse, and pustular psoriasis.1 Plaque psoriasis is characterized by hyperproliferation and poor differentiation of epidermal keratinocytes, by inflammation of the epidermis and dermis, and by profound alterations in the cutaneous vascular system.2 At one time, these changes were thought to be triggered by a dysfunction of keratinocytes, which then secondarily activated the delayed hypersensitivity response.3 Recent findings, however, suggest that the mechanism is primarily immunological. The observation that drugs such as cyclosporine and methotrexate can reduce the symptoms of psoriasis,4 combined with the discovery of activated, proliferating T-cell infiltration in epidermal plaques,5 strongly suggests that the disorder is due to alterations in the cell-mediated immune response. Psoriasis, however, is still not curable, and existing therapies focus on the control of its symptoms. Patients seek therapy to relieve pain and itching, which can be disabling, and to ameliorate cosmetic disfigurement. The goal of current psoriasis therapies, in short, is to minimize the severity and extent of the disease and its concomitant interference with quality of life.6 Today there are many therapies for psoriasis, all with varying degrees of effectiveness and safety. Salicylic acid is one commonly used topical agent;6 however, although salicylic acid has been known for more than a century,7 there is a remarkable lack of published data on its use in psoriasis. To assess the role of salicylic acid in the treatment of psoriasis, a consensus panel was convened at a roundtable discussion held in New York City on July 29, 1997. The results of this roundtable, including guidelines for the use of salicylic acid in psoriasis, will be presented in this review.
This paper references
10.1016/S0190-9622(88)80237-8
Methotrexate in psoriasis: revised guidelines.
H. Roenigk (1988)
Conventional remedies, future therapies, and alternative treatments for psoriasis
M. Lebwohl (1993)
10.1016/S0190-9622(86)70206-5
Effect of continued ultraviolet B phototherapy on the duration of remission of psoriasis: a randomized study.
R. Stern (1986)
Current therapy of psoriasis.
R. G. Shoss (1977)
10.1111/1523-1747.EP12541294
Augmentation of oral methoxsalen-photochemotherapy with an oral retinoic acid derivative.
P. Fritsch (1978)
10.1111/j.1365-2133.1980.tb06590.x
Detection of the action of salicylic acid on the normal stratum corneum
D. L. Roberts (1980)
Keratolytic’’ effects of salicylic acid
C Huber (1977)
10.1111/j.1346-8138.1976.tb01833.x
THE PERCUTANEOUS ABSORPTION OF SALICYLIC ACID
H. Takahashi (1976)
Efficacy and tolerance of betamethasone dipropionate plus salicylic acid (Diprosalic® Lotion) in the treatment of psoriasis
M. Palatsi (1981)
10.1016/S0190-9622(94)70237-3
Comparative study of calcipotriene (MC 903) ointment and fluocinonide ointment in the treatment of psoriasis.
S. Bruce (1994)
Efficacy and tolerance of betamethasone dipropionate plus salicylic acid in the treatment of psoriasis and other steroid-responsive dermatoses
H. Lindemayr (1981)
10.1111/1523-1747.EP12676615
A keratolytic gel containing salicylic acid in propylene glycol.
H. Baden (1973)
10.1111/j.1365-2133.1980.tb15831.x
Therapy of psoriasis: comparison of photochemotherapy and several variants of phototherapy
H. Weelden (1980)
10.1056/NEJM197909063011016
Cyclosporin A for psoriasis.
W. Müller (1979)
10.1159/000251346
Dermatopharmacology of salicylic acid. I. Range of dermatotherapeutic effects of salicylic acid.
Weirich Eg (1975)
A double - blind comparison of calcipotriol and betamethasone © 1999 Blackwell Science Ltd International Journal of Dermatology 1999 , 38 , 16 – 24 valerate in treatment of psoriasis vulgaris
K Kragballe (1991)
A double-blind comparison of betamethasone dipropionate with salicyclic acid (diprosalic) and budesonide ointment in the treatment of psoriasis
K. Kuokkanen (1983)
10.1136/pgmj.57.666.271-b
Essential Immunology
(1981)
10.1016/S0190-9622(87)70221-7
Treatment of resistant severe psoriasis with systemic cyclosporine.
D. D. Picascia (1987)
10.1016/S0190-9622(86)70201-6
Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris.
J. Bernstein (1986)
10.1056/NEJM198405033101805
Cutaneous squamous-cell carcinoma in patients treated with PUVA.
R. Stern (1984)
10.1080/21548331.2000.11444034
Current Treatment Options in Psoriasis
A. Khachemoune (2000)
Development and incidence of cancer following cyclosporine therapy.
I. Penn (1986)
10.1159/000137257
Binding of adrenaline and isoprenaline to plasma proteins of the dog.
F. Teixeira (1979)
USPDI: Drug Information for the Health Care Professional
(1997)
10.1016/s0190-9622(87)70037-1
Continuing medical education (Therapy)
C. Ellis (1987)
10.1111/ijd.1979.18.3.228
Systemic Absorption of Topical Salicylic Acid
B. Birmingham (1979)
10.1016/S0190-9622(94)70066-4
Response of psoriasis to a new topical retinoid, AGN 190168.
T. Esgleyes-Ribot (1994)
A doubleblind comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
K Kragballe (1991)
Is topical therapy effective for psoriasis?: results of survey of U.S. dermatologists
WH Liem (1992)
10.1001/ARCHDERM.1992.01680210057007
T-cell activation is potentiated by cytokines released by lesional psoriatic, but not normal, epidermis.
E. Y. Chang (1992)
10.1056/NEJM199101313240501
Cyclosporine for plaque-type psoriasis. Results of a multidose, double-blind trial.
C. Ellis (1991)
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
Malfitan Va (1983)
10.1007/BF00741846
“Keratolytic” effect of salicylic acid
C. Huber (2004)
10.1016/S0190-9622(84)70204-0
Retinoids: a review.
C. Dicken (1984)
10.1016/S0190-9622(08)80253-8
Retinoids in psoriasis and disorders of keratinization.
P. Fritsch (1992)
[On the treatment of psoriasis].
A. Vaag (1962)
10.1001/ARCHDERM.1987.01660340065021
The treatment of severe psoriasis. A national survey.
P. Peckham (1987)
10.1001/ARCHDERM.1981.01650080019020
Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study.
M. Pittelkow (1981)
10.1016/0738-081X(91)90081-U
Cyclosporine A in psoriasis.
A. Rebora (1991)
A doubleblind comparison of calcipotriol and betamethasone
K Kragballe (1999)
10.1056/NEJM199306243282511
Psoriasis therapy--observational or rational?
G. Krueger (1993)
Betamethasone dipropionate and salicylic acid lotion for nonscalp dermatoses.
V. A. Malfitan (1983)
Skin manifestation of psoriasis
HH Roenigk (1991)
PUVA and skin cancer
AB Forman (1991)
10.1111/j.1365-2133.1976.tb00825.x
Studies on the effect of salicylic acid on normal skin
M. Davies (1976)
10.1016/S0190-9622(89)70286-3
Topical corticosteroid compounding: effects on physicochemical stability and skin penetration rate.
L. Krochmal (1989)
10.1016/S0190-9622(83)70033-2
Recent advances in the treatment of psoriasis.
E. Farber (1983)
Etretinate therapy.
C. Ellis (1987)
Editorial: Psoriasis therapy—observational or rational
GG Krueger (1993)
10.1111/1523-1747.EP12496022
Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.
J. Melski (1977)
10.1016/S0190-9622(86)70298-3
Weekly pulse dosing schedule of fluorouracil: a new topical therapy for psoriasis.
D. Pearlman (1986)
10.1016/S0190-9622(82)70005-2
Combined methotrexate-PUVA therapy in the treatment of psoriasis.
W. Morison (1982)
Betamethasone dipropionate and salicylic acid (Diprosalic®) in the treatment of psoriasis
K. Kuokkanen (1978)
10.1016/0140-6736(91)92157-W
Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris
K. Kragballe (1991)
Topical therapy for psoriasis.
M. Lebwohl (1995)
10.2165/00003495-199243040-00010
Acitretin : A Review of its Pharmacology and Therapeutic Use.
T. Pilkington (1992)
10.1016/0140-6736(91)91493-E
Calcipotriol and hypercalcaemia
C. Dwyer (1991)
10.1016/0002-9343(84)90356-5
Side effects of systemic cyclosporine in patients not undergoing transplantation.
A. Palestine (1984)
10.1016/0190-9622(92)70060-S
Effects of petrolatum on stratum corneum structure and function.
R. Ghadially (1992)
Side effect profile of retinoids
WJ Cunningham (1991)
Dermatopharmacology of salicylic acid
EG Weirich (1975)
Retinoid combinations
C Grupper (1991)
10.1177/030006058301100208
Effect of Salicylic Acid on the Activity of Betamethasone-17,21-Dipropionate in the Treatment of Erythematous Squamous Dermatoses
Robert Elic (1983)



This paper is referenced by
Investigation of chemical components and pharmaceutical potential of Carpobrotus species
Rr Vennavaram (2007)
10.1007/978-3-319-90107-7
Evidence-Based Psoriasis
Tina Bhutani Wilson Liao (2018)
10.1016/j.jaad.2020.07.087
fJoint AAD-NPF Guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures.
Craig A. Elmets (2020)
10.1684/ejd.2014.2294
Recommendations for adjunctive basic skin care in patients with psoriasis
T. Luger (2014)
10.1586/EDM.12.18
Effective topical agents and emerging perspectives in the treatment of psoriasis
A. Chiricozzi (2012)
10.1111/J.1610-0379.2011.07680.SUPP.X
S3 – Guidelines on the treatment of psoriasis vulgaris Update 2011
A. Nast (2011)
10.1016/j.jaad.2009.08.026
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy.
A. Menter (2010)
10.1177/247553031016a00203
Topical Treatment of Mild to Moderate Psoriasis
Daniel Gold (2010)
10.1007/978-3-540-46911-7_19
Disorders of the Scalp
R. Sinclair (2008)
10.2217/EBO.11.27
Current treatment options in psoriasis: topical agents
Kristine B. Zitelli (2011)
Maisto įtaka žvynelinės kontrolei ir gydymui, remiantis klinikinių tyrimų duomenimis
Indrė Domarkaitė-Jakovlevė (2012)
10.1007/978-3-642-27606-4_19
Psoriasis and dry skin: The impact of moisturizers
J. Fluhr (2012)
10.3109/9781420088618-10
Treatment of Mild-to-Moderate Psoriasis with Coal Tar, Anthralin, Salicylic Acid and Lactic Acid
S. Fitzmaurice (2006)
10.7547/8750-7315-2016.1.VLAHOVIC
What is the Standard of Treatment for Plantar Psoriasis
Thomas B. Birdwell (2016)
10.1371/journal.pone.0080751
Novel Factors in the Pathogenesis of Psoriasis and Potential Drug Candidates Are Found with Systems Biology Approach
M. Manczinger (2013)
10.1111/srt.12062
Psoriasis plaque test with confocal microscopy: evaluation of different microscopic response pathways in NSAID and steroid treated lesions
M. Ardigó (2013)
10.5812/JJNPP.14077
Effect of Achillea millefolium Mouthwash on Oral Mucositis Induced by Chemotherapy in AML Patients
Telka Hajisalem (2019)
10.1201/B14276-22
Summary of Therapeutic Options for Mild-to-Moderate Psoriasis
C. Berthelot (2006)
Towards a comprehensive resource for elucidating the pathogenesis of inherited keratodermas
M. Zamiri (2010)
10.1111/J.1610-0387.2006.06172.X
S3‐Leitlinie zur Therapie der Psoriasis vulgaris
A. Nast (2006)
10.5772/intechopen.90626
Medical Management of Chronic Plaque Psoriasis in the Modern Age
Teodora-Larisa Timis (2019)
10.1111/J.1610-0387.2007.06172.X
Evidence‐based (S3) guidelines for the treatment of psoriasis vulgaris
A. Nast (2007)
10.1159/000083706
Dermal Capillary Clearance: Physiology and Modeling
K. Kretsos (2005)
Tratamientos tópicos de la psoriasis: actualización
J. A. M. Romero (2005)
10.1111/j.1365-2133.2005.06781.x
Diet and psoriasis: experimental data and clinical evidence
M. Wolters (2005)
Tratamientos tópicos de la psoriasis: actualización Topical treatment of psoriasis: An update
M. J. Manresa (2005)
Evidence-Based Review of Topical Treatments for Psoriasis
M. Mikhail (2004)
10.1111/ddg.12615
Importance of basic therapy in psoriasis
D. Thąci (2015)
10.1016/S0738-081X(01)00192-4
Antiperspirants and deodorants.
A. Benohanian (2001)
Western healers in traditional Chinese medicine in recent years
(2008)
10.2147/PTT.S130295
Single-center, noninterventional clinical trial to assess the safety, efficacy, and tolerability of a dimeticone-based medical device in facilitating the removal of scales after topical application in patients with psoriasis corporis or psoriasis capitis
Ulrich R. Hengge (2017)
10.3389/fphar.2017.00125
East Indian Sandalwood Oil (EISO) Alleviates Inflammatory and Proliferative Pathologies of Psoriasis
M. Sharma (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar